Priority Date: 05.07.12 (EP 20120175204)

NEW TREATMENT FOR NEURODEGENERATIVE DISEASES

  • Application ID: EP13734067
  • Status: GRANT OF PATENT INTENDED

Attorney

no operation time available
1 office
Technology Company

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 174 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 05.07.2012 - Priority Date (EP 20120175204)
  • 09.01.2014 - Publication A1 (WO2014006114)
  • 13.05.2015 - Publication A1 (EP2870242)